You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letter
Is diuretic use beneficial or harmful for patients with chronic kidney disease?
  1. Yusra Habib Khan1,2,
  2. Azmi Sarriff1,
  3. Tauqeer Hussain Mallhi1,2,
  4. Azreen Syazril Adnan2,
  5. Amer Hayat Khan1
  1. 1 Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, University Sains Malaysia, Penang, Malaysia
  2. 2 Chronic Kidney Disease Resource Centre, School of Medical Sciences, Health Campus, University Sains Malaysia, Kubang Kerain, Kelantan, Malaysia
  1. Correspondence to Dr Yusra Habib Khan; yusrahabib{at}ymail.com

https://doi.org/10.1136/ejhpharm-2017-001285

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Chronic kidney disease (CKD) is a global health concern that arises as a result of a number of different insults to renal function.1 Progression of CKD to end-stage renal disease is a costly and important clinical event with substantial morbidity.2 Additionally, increase in demand for renal replacement therapy (RRT) makes it important to investigate factors associated with the progression of CKD and the prognosis of earlier stages of CKD.

    A retrospective study was conducted of subjects with an estimated glomerular filtration rate (eGFR) between 15 and 59 mL/min/1.73 m2 during a 2-year study period from a hospital database. A total of 621 patients of mean age 61.09±6.57 years were identified. At …

    View Full Text

    Footnotes

    • EAHP Statement 4: Clinical Pharmacy Services.

    • Contributors TM, YHK and ASA provided substantial contributions to the conception or design of the work. TM and AS were involved in the acquisition, analysis and interpretation of data. TM and AHK were responsible for drafting the work or revising it critically for important intellectual content. AHK and ASA gave final approval of the version to be published. A

    • Competing interests None declared.

    • Ethics approval Jawatankuasa Etika Penyelidikan (Manusia) of USM (JEPeM).

    • Provenance and peer review Not commissioned; internally peer reviewed.